33 research outputs found
The Libyan collections in FI (Herbarium Centrale Italicum and Webb Herbarium) and studies on the Libyan Flora by R. Pampanini - Part 2
This work is the continuation of Part 1, published in 2015, and comprises the reconstruction of the original collections of new taxa described by R. Pampanini and other botanists and, where possible, typification of the new names and taxonomical updating. The material studied for the most part concerns Libyan specimens held in the FI and FI-W herbaria but in some case also K, LD, MPU, P, PAD, PAL, ULT. Other material, which Pampanini studied in Florence was subsequently conserved in other herbaria. Specimens belonging to 21 families have been examined, from the Najadaceae to Zygophyllaceae. As well as typification, bibliographical data have been provided for those already typified. In this second part, a total of 113 names have been indexed and 91 typified, taking the names validly published in the entire work to 353, of which 286 are typified. Also on this occasion, we have provided taxonomic updates for each taxon. The Conclusions present a synthetic sum of the taxa still recognised taxonomically (entirely, in new combinations, or with a new status) in recent works on the Flora of N. Africa, in general revisions of various systematic groups, or reconsidered by the authors of this present work. We have also investigated the phyto-geographic origins of the taxa [according to the dominions proposed by Quézel (1978) for N. Africa]. Finally we have very briefly indicated the presence of material of the R. Pampanini collections (for Cyrenaica, together with R. E. G. Pichi Sermolli in 1934) in the most important herbaria. The paragraph "Addenda et Corrigenda" has been added to the final part of the treatise and relates chiefly to taxa omitted from the first part, either on account of new information or as a result of errors which came to light after publication
The Natural History Museum of Florence and its contribution to the knowledge of the Mediterranean.
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions
Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico, CNPq: PQ-2017#305529/2017-0Deutsche Forschungsgemeinschaft, DFG: MA 1876/12-1Alexander von Humboldt-Stiftung: 88881.136091/2017-01RVO-VFN64165, 26/203.214/20172018.070.1Associazione Italiana per la Ricerca sul Cancro, AIRC: IG2015, 17593Coordenação de Aperfeiçoamento de Pessoal de NÃvel Superior, CAPESCancer Australia: PdCCRS1128727CancerfondenBarncancerfondenVetenskapsrÃ¥det, VRCrafoordska StiftelsenKnut och Alice Wallenbergs StiftelseLund University Medical Faculty FoundationXiamen University, XMU2014S0617-74-30019C7838/A15733Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNSF: 31003A_140913CNIBInstitut National Du Cancer, INCaR01 NCI CA167824National Institutes of Health, NIH: S10OD0185222016/2017, 02R/2016AU 525/1-1Deutschen Konsortium für Translationale Krebsforschung, DKTK70112951Smithsonian Institution, SIIsrael Science Foundation, ISFAustrian Science Fund, FWF: W1212SFB-F06107, SFB-F06105Acknowledgements BAL received a fellowship provided by CAPES and the Alexander von Humboldt Foundation (#88881.136091/2017-01). ME is supported by CNPq (PQ-2017#305529/2017-0) and FAPERJ-JCNE (#26/203.214/2017) research scholarships, and ZZ by grant RVO-VFN64165. GC is supported by the AIRC Investigator grant IG2015 grant no. 17593 and RS by Cancer Australia grant PdCCRS1128727. This work was supported by grants to RM from the “Georg und Franziska Speyer’sche Hochsschulstiftung”, the “Wilhelm Sander foundation” (grant 2018.070.1) and DFG grant MA 1876/12-1.Acknowledgements This work was supported by The Swedish Childhood Cancer Foundation, The Swedish Cancer Society, The Swedish Research Council, The Knut and Alice Wallenberg Foundation, BioCARE, The Crafoord Foundation, The Per-Eric and Ulla Schyberg Foundation, The Nilsson-Ehle Donations, The Wiberg Foundation, and Governmental Funding of Clinical Research within the National Health Service. Work performed at the Center for Translational Genomics, Lund University has been funded by Medical Faculty Lund University, Region Skåne and Science for Life Laboratory, Sweden.Acknowledgements This work was supported by the Fujian Provincial Natural Science Foundation 2016S016 China and Putian city Natural Science Foundation 2014S06(2), Fujian Province, China. Alexey Ste-panov and Alexander Gabibov were supported by Russian Scientific Foundation project No. 17-74-30019. Jinqi Huang was supported by a doctoral fellowship from Xiamen University, China.Acknowledgments This work was supported by the Swiss National Science Foundation (grant 31003A_140913; OH) and the Cancer Research UK Experimental Cancer Medicine Centre Network, Cardiff ECMCI, grant C7838/A15733. We thank N. Carpino for the Sts-1/2 double-KO mice.Acknowledgements This work was supported by the French National Cancer Institute (INCA) and the Fondation Française pour la Recherche contre le Myélome et les Gammapathies (FFMRG), the Intergroupe Francophone du Myélome (IFM), NCI R01 NCI CA167824 and a generous donation from Matthew Bell. This work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai. Research reported in this paper was supported by the Office of Research Infrastructure of the National Institutes of Health under award number S10OD018522. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors thank the Association des Malades du Myélome Multiple (AF3M) for their continued support and participation. Where authors are identified as personnel of the International Agency for Research on Cancer / World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer / World Health Organization.We are indebted to all members of our groups for useful discussions and for their critical reading of the manuscript. Special thanks go to Silke Furlan, Friederike Opitz and Bianca Killing. F.A. is supported by the Deutsche For-schungsgemeinschaft (DFG, AU 525/1-1). J.H. has been supported by the German Children’s Cancer Foundation (Translational Oncology Program 70112951), the German Carreras Foundation (DJCLS 02R/2016), Kinderkrebsstiftung (2016/2017) and ERA PerMed GEPARD. Support by Israel Science Foundation, ERA-NET and Science Ministry (SI). A. B. is supported by the German Consortium of Translational Cancer Research, DKTK. We are grateful to the Jülich Supercomputing Centre at the Forschungszemtrum Jülich for granting computing time on the supercomputer JURECA (NIC project ID HKF7) and to the “Zentrum für Informations-und Medientechnologie” (ZIM) at the Heinrich Heine University Düsseldorf for providing computational support to H. G. The study was performed in the framework of COST action CA16223 “LEGEND”.Funding The work was supported by the Austrian Science Fund FWF grant SFB-F06105 to RM and SFB-F06107 to VS and FWF grant W1212 to VS
The Libyan Collections of vascular plants by Fridiano Cavara: museological importance and holdings of nomenclatural types
The first description of Cavara Libyan collection in NAP is given, highlighting its relevance
among the Libyan collection present in Italian Herbaria in terms of specimen number and diversity of genera represented.
The names of 19 taxa belonging to 9 families and described by Cavara, sometimes jointly with
Trotter, or Grande, and by other botanists (Pampanini and Hackel) on material collected by
Cavara, are here typified. Types previously designated by others are also listed and referenced.
A new combination and status novus Limonium hirtiflorum (Cavara) Cuccuini is propose